Cargando…

Editorial: Targeting glucose metabolism in cancer immunity and immunotherapy

Detalles Bibliográficos
Autores principales:	Feron, Olivier, Chang, Chih-Hao, Végran, Frédérique
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10031061/ https://www.ncbi.nlm.nih.gov/pubmed/36969153 http://dx.doi.org/10.3389/fimmu.2023.1171274

Ejemplares similares

Editorial: Targeting Metabolism in Cancer Immunotherapy
por: Roszik, Jason, et al.
Publicado: (2018)

Editorial: Novel Strategies for Cancer Immunotherapy: Targeting Immune-Mediated Suppressive Mechanisms
por: Lafont, Virginie, et al.
Publicado: (2021)

Editorial: Extracellular traps in cancer immunity and immunotherapy
por: Rahat, Michal A., et al.
Publicado: (2023)

Editorial: Adenosine pathways in cancer immunity and immunotherapy
por: Fu, Junjiang, et al.
Publicado: (2023)

Editorial: Immune Checkpoint Molecules and Cancer Immunotherapy
por: Bazhin, Alexandr V., et al.
Publicado: (2018)

Editorial: Emerging talents in cancer immunity and immunotherapy: 2022
por: Maeurer, Markus
Publicado: (2023)

Editorial: Rising stars in cancer immunity and immunotherapy 2022
por: Goyvaerts, Cleo, et al.
Publicado: (2023)

Editorial: Engineered immune cells in cancer immunotherapy (EICCI)
por: Martin, Francisco, et al.
Publicado: (2022)

Editorial: Immune Outposts on the Inflammatory Frontier: Tertiary Lymphoid Structures as Targets for Immunotherapy of Cancer and Autoimmunity
por: Silina, Karina, et al.
Publicado: (2019)

Editorial: Updates on toll-like receptors in cancer immunity and immunotherapy
por: Hoden, Bettina, et al.
Publicado: (2023)

Editorial: Post-translational modifications of proteins in cancer immunity and immunotherapy
por: Dai, Xiangpeng, et al.
Publicado: (2022)

Immunogenic Cell Death and Role of Nanomaterials Serving as Therapeutic Vaccine for Personalized Cancer Immunotherapy
por: Catanzaro, Elena, et al.
Publicado: (2022)

Editorial: Screening and verification of new targets for CAR-T immunotherapy in cancer
por: Su, Yang, et al.
Publicado: (2023)

Editorial: Combinational immunotherapy of cancer: novel targets, mechanisms, and strategies
por: Nan, Yanyang, et al.
Publicado: (2023)

Editorial: The relationship between COVID-19 severity and cancer immunity and immunotherapy
por: Nunès, Jacques A., et al.
Publicado: (2023)

Editorial: Heterologous Immunity: Implications and Applications in Vaccines and Immunotherapies
por: Singh, Shakti, et al.
Publicado: (2020)

Editorial: Non-coding RNA in immunotherapies and immune regulation
por: Kaeffer, Bertrand, et al.
Publicado: (2022)

Editorial: Targeting metabolism to activate T cells and enhance the efficacy of checkpoint blockade immunotherapy in solid tumors
por: Xia, Zhijia, et al.
Publicado: (2023)

Targeting Glucose Metabolism to Enhance Immunotherapy: Emerging Evidence on Intermittent Fasting and Calorie Restriction Mimetics
por: Turbitt, William J., et al.
Publicado: (2019)

Editorial: Crosstalk between innate and adaptive immunity in colorectal cancer: Implications for immunotherapy
por: Jarry, Anne, et al.
Publicado: (2023)

Editorial: “Cancer Immunotherapy: Lights and Shadows”
por: Barrio, María Marcela, et al.
Publicado: (2015)

Editorial: NKT Cells in Cancer Immunotherapy
por: Webb, Tonya J., et al.
Publicado: (2020)

Editorial: Targeting the Tumor Microenvironment for a More Effective and Efficient Cancer Immunotherapy
por: Chouaib, Salem, et al.
Publicado: (2020)

Editorial: Targeting Indoleamine 2,3-dioxygenases and Tryptophan Dioxygenase for Cancer Immunotherapy
por: Brochez, Lieve, et al.
Publicado: (2021)

Editorial: Cancer Prevention: Targeting Premalignant Epithelial Neoplasms in the Era of Cancer Immunotherapy and Vaccines
por: Çuburu, Nicolas, et al.
Publicado: (2022)

Editorial: The challenge of immunity evaluation and immunotherapy in gynecologic and urologic oncology
por: Tan, Ruirong, et al.
Publicado: (2023)

Editorial: The role of multi-omics variants in tumor immunity and immunotherapy
por: Chen, Shuang, et al.
Publicado: (2022)

Editorial: Metabolism and Immune Tolerance
por: Howie, Duncan, et al.
Publicado: (2018)

Editorial: Interplay between oncomicrobes, the microbiota and the immune system: impact on responses to cancer immunotherapy
por: Dorta-Estremera, Stephanie M., et al.
Publicado: (2023)

Editorial: Nanobody-based cancer immunotherapy and immunoimaging
por: Jafari, Mahdie, et al.
Publicado: (2023)

Editorial: NK Cell-Based Cancer Immunotherapy
por: Borrego, Francisco, et al.
Publicado: (2016)

Erratum: Editorial: NKT Cells in Cancer Immunotherapy
Publicado: (2020)

Editorial: CD4(+) T Cells in Cancer Immunotherapies
por: González-Navajas, José M., et al.
Publicado: (2021)

Improving Cancer Immunotherapy: Exploring and Targeting Metabolism in Hypoxia Microenvironment
por: Wei, Jinfen, et al.
Publicado: (2022)

Alternative Splicing in Cancer and Immune Cells
por: Bernard, Antoine, et al.
Publicado: (2022)

Editorial: The Spectrum of Lymphoid Subsets in Allergic Diseases: Immune Regulation and Immunotherapy
por: Liu, Zheng, et al.
Publicado: (2022)

Editorial: The intricate innate immune-cancer cell relationship in the context of tumor angiogenesis, immunity and microbiota: The angiogenic switch in the tumor microenvironment as a key target for immunotherapies
por: Mortara, Lorenzo, et al.
Publicado: (2022)

Reprogramming Immune Cells for Enhanced Cancer Immunotherapy: Targets and Strategies
por: Dong, Yan, et al.
Publicado: (2021)

Editorial: Community series in post-translational modifications of proteins in cancer immunity and immunotherapy, volume II
por: Nihira, Naoe Taira, et al.
Publicado: (2023)

Editorial: The immunosuppressive tumor microenvironment and strategies to revert its immune regulatory milieu for cancer immunotherapy
por: Ganjalikhani Hakemi, Mazdak, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_3kvd83nre193qt2g6ubdib7g74